Co-Authors
This is a "connection" page, showing publications co-authored by BORIS SEPESI and SHARON HERMES GIORDANO.
Connection Strength
0.493
-
Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2018 05 01; 53(5):960-966.
Score: 0.158
-
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. J Clin Oncol. 2017 Oct 10; 35(29):3354-3362.
Score: 0.150
-
Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection. Ann Thorac Surg. 2023 Nov; 116(5):1020-1027.
Score: 0.055
-
Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer. Pain. 2019 10; 160(10):2365-2373.
Score: 0.043
-
Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 02; 159(2):691-702.e5.
Score: 0.043
-
Persistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study. Ann Thorac Surg. 2020 01; 109(1):194-202.
Score: 0.043